Edition:
United Kingdom

People: Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

3.25USD
5:26pm GMT
Change (% chg)

$0.30 (+10.17%)
Prev Close
$2.95
Open
$3.50
Day's High
$3.61
Day's Low
$3.19
Volume
262,839
Avg. Vol
33,973
52-wk High
$5.90
52-wk Low
$2.05

Ames, Constance 

Ms. Constance Ames is Vice President - Finance of Axsome Therapeutics, Inc. Ms. Ames joined us from Keryx Biopharmaceuticals, Inc., which she joined in 2010, where she served in a variety of roles of increasing responsibility, most recently as Senior Director, Finance and Accounting. During her tenure there, Ms. Ames played a critical role in growing the finance and accounting department through Keryx's transition from a development-stage company to a fully integrated commercial organization. She was also responsible for leading Keryx's compliance with Securities and Exchange Commission rules and regulations. Prior to joining Keryx, she was with Deloitte and Touche, LLP, independent certified public accountants, where she served as a senior associate. Ms. Ames received a Bachelor of Science in accounting from Ithaca College and is a member of the American Institute of Certified Public Accountants.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --